Advent

Advent Technologies Secures $1.1 Million Contract to Supply its HT-PEM MEAs for Fuel Cell-Powered Trucks in Asia

Retrieved on: 
木曜日, 5月 11, 2023
Hardware, Alternative Energy, Energy, Green Technology, Manufacturing, Alternative Vehicles, Fuels, Technology, EV, Electric Vehicles, Other Transport, Environment, Trucking, Transport, Automotive, Other Energy, Engineering, Proton, Methanol, ADN, MEA, EVS, Membrane, Electrode, Natural gas, High Temperature Proton Exchange Membrane fuel cell, Membrane electrode assembly, Fine chemical, Electric battery, Advent

Under this contract, Advent will supply High-Temperature Proton Exchange Membrane ("HT-PEM") Membrane Electrode Assemblies ("MEAs") to support the development of advanced fuel cell solutions for trucks.

Key Points: 
  • Under this contract, Advent will supply High-Temperature Proton Exchange Membrane ("HT-PEM") Membrane Electrode Assemblies ("MEAs") to support the development of advanced fuel cell solutions for trucks.
  • Starting in the second quarter of 2023, Advent will begin delivering HT-PEM MEAs, with a projected continuation of deliveries in accordance with the customer's specified timeframe.
  • Advent is committed to play a significant role in facilitating this transition, and we are excited to continue expanding customer relationships across Asia.
  • We look forward to further contributing to a sustainable future for heavy-duty transportation applications through the adoption of HT-PEM fuel cell technology."

BASF and Advent Technologies sign agreement to establish end-to-end supply chain for hydrogen fuel cell systems in Europe

Retrieved on: 
火曜日, 5月 9, 2023
Technology, Manufacturing, Other Energy, Other Manufacturing, Alternative Energy, Environment, Energy, Engineering, Machinery, Hardware, Machine Tools, Metalworking & Metallurgy, PGM, Partnership, Senior, HT, Methanol, ADN, MEA, Multimedia, Temperature, Recycling, Membrane, Catalysis, Advent, BASF, Growth, Platinum, Palladium, Fine chemical

Advent is the largest manufacturer of HT-PEM fuel cell systems targeting emerging markets in the field of sustainable and decentralized energy such as stationary power that can replace diesel generators, marine power from e-methanol fuel cells and heavy-duty mobility.

Key Points: 
  • Advent is the largest manufacturer of HT-PEM fuel cell systems targeting emerging markets in the field of sustainable and decentralized energy such as stationary power that can replace diesel generators, marine power from e-methanol fuel cells and heavy-duty mobility.
  • HT-PEM fuel cells operate at 120 to 180°C, offer a broad operating window and tolerate impurities in the hydrogen fuel gas.
  • Advent offers competitive fuel cell systems for stationary and portable applications based on methanol and on-site reforming.
  • “We are committed to building a full loop supply chain for green hydrogen technologies including precious metal services, catalysts, components and recycling.

Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion

Retrieved on: 
月曜日, 5月 8, 2023
Biotechnology, Pharmaceutical, Finance, Health, Banking, Health Technology, Professional Services, Health Insurance, IC Group, West Pharmaceutical Services, DSM-IV codes, Partnership, Modernizing Medicine, ICE, Health care, Baxter, Infection, Perella Weinberg Partners, Cleary Gottlieb Steen & Hamilton, Summit Health, Baxter International, Warburg Pincus, Bausch & Lomb, Dendrite International, Inc. v. Doe No. 3, Oliver Cromwell, Truist, Ropes & Gray, CDMO, Syneos Health, Sullivan & Cromwell, Patient, Investment, Advent International, Growth, NYSE, BPS, Fine chemical, Pharmaceutical industry, Advent

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
  • Under the terms of the definitive agreement, Baxter will receive $4.25 billion in cash, subject to certain closing adjustments, with net after-tax proceeds currently estimated to be approximately $3.4 billion.
  • Baxter intends to utilize the after-tax proceeds to reduce its debt, consistent with the company’s stated capital allocation priorities.
  • Advent International and Warburg Pincus have extensive experience helping innovative healthcare companies advance their mission and strategic priorities.

Advent Resources Launches Latest Version of All-in-One Car Sales System; Addresses FTC Car Dealer Regulation Proposals

Retrieved on: 
木曜日, 4月 27, 2023
Car dealership, Workflow, Automotive News, Tax, Sale, EVS, FTC, CRM, Ecosystem, OEM, DMS, Online shopping, Security (finance), Risk management, DALLAS, Advent

DALLAS, April 27, 2023 /PRNewswire-PRWeb/ -- Advent Resources, creator of the most sophisticated all-in-one car sales system for dealers, today announced the launch of Advent Advantage. This latest version of the company's high performance sales system features even more robust capabilities to help dealers capture every penny of profitability on every deal, in the most efficient way possible.

Key Points: 
  • DALLAS, April 27, 2023 /PRNewswire-PRWeb/ -- Advent Resources, creator of the most sophisticated all-in-one car sales system for dealers, today announced the launch of Advent Advantage.
  • For over 35 years, Advent has brought together complex components of the car deal, refined each step, and simplified them into a single selling process.
  • This fully digital platform is used from the first interaction with the consumer all the way through to the e-signing ceremony.
  • "The deal is the most important part of the car sale, yet today's dealers toggle between multiple systems with different numbers," said Ben Gill, CEO of Advent Resources.

Sunley House Changes Name to Advent Global Opportunities

Retrieved on: 
水曜日, 4月 26, 2023
Professional Services, Finance, Advent International, Partnership, International, Fine chemical, Advent

Advent International (“Advent” or the “firm”), one of the largest and most experienced global private equity investors, today announced that Sunley House, the firm’s global investment platform focused on public and select private opportunities, has changed its name to Advent Global Opportunities, better reflecting the platform’s integration and partnership with Advent.

Key Points: 
  • Advent International (“Advent” or the “firm”), one of the largest and most experienced global private equity investors, today announced that Sunley House, the firm’s global investment platform focused on public and select private opportunities, has changed its name to Advent Global Opportunities, better reflecting the platform’s integration and partnership with Advent.
  • Launched in 2015, Advent Global Opportunities manages a concentrated portfolio of high-quality, high-conviction positions in public and select private companies.
  • “We are excited for this new chapter for Advent Global Opportunities as we continue to support the team’s momentum and invest in its future success.”
    “Today’s announcement further emphasizes who we are and how we have evolved since our inception, as well as the strong and beneficial connection we have with Advent,” said Mohammed Anjarwala, Co-founder and Managing Director of Advent Global Opportunities.
  • We believe our flexible global mandate positions us to capture the most attractive opportunities in today’s dynamic environment, and we are thrilled to move forward embracing the Advent name.”

Maxar Technologies Stockholders Approve Acquisition by Advent International

Retrieved on: 
水曜日, 4月 19, 2023
Telecommunications, Satellite, Photography, Defense, Other Defense, Technology, Aerospace, Manufacturing, Slate, Agreement, Plan, Covington & Burling, Wachtell, Lipton, Rosen & Katz, USAF, General Howell, Morgan Stanley, Milbank, Skadden, Arps, Slate, Meagher & Flom, Crown corporations of Canada, Special, Advent International, TSX, III, NYSE, Weil, Gotshal & Manges, Financial adviser, Shareholder, Maxar Technologies, Advent

Maxar Technologies (NYSE:MAXR) (TSX:MAXR) (“Maxar” or the “Company”), provider of comprehensive space solutions and secure, precise, geospatial intelligence, announced that at Maxar’s Special Meeting of Stockholders (the “Special Meeting”) held earlier today, the Company’s stockholders voted to adopt the Agreement and Plan of Merger (the “merger agreement”), whereby Maxar will be acquired by Advent International (“Advent”), one of the largest and most experienced global private equity investors.

Key Points: 
  • Maxar Technologies (NYSE:MAXR) (TSX:MAXR) (“Maxar” or the “Company”), provider of comprehensive space solutions and secure, precise, geospatial intelligence, announced that at Maxar’s Special Meeting of Stockholders (the “Special Meeting”) held earlier today, the Company’s stockholders voted to adopt the Agreement and Plan of Merger (the “merger agreement”), whereby Maxar will be acquired by Advent International (“Advent”), one of the largest and most experienced global private equity investors.
  • Under the terms of the merger agreement, Maxar stockholders will receive $53.00 per share in cash for every share of Maxar common stock they own immediately prior to the effective time of the merger.
  • J.P. Morgan Securities LLC is serving as financial advisor to Maxar and Wachtell, Lipton, Rosen & Katz is serving as lead counsel to Maxar.
  • Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC are serving as financial advisors to Advent and Weil, Gotshal & Manges LLP is serving as lead counsel to Advent.

Advent Technologies hosts Grand Opening of its State-of-the-Art Fuel Cell R&D and Manufacturing Facility in Boston

Retrieved on: 
火曜日, 4月 4, 2023
Hardware, Alternative Energy, State, Local, Green Technology, Energy, Sustainability, Manufacturing, Technology, Batteries, Environmental Policy, Environment, Public Policy, Government, Environmental Health, Other Manufacturing, Other Energy, Engineering, Hydrogen, U.S. Department of Defense Strategy for Operating in Cyberspace, Ion, ADN, Los Alamos National Laboratory, Climate change mitigation, Multimedia, MEA, Electrochemistry, Development, Gross regional domestic product, Electrode, 101 Clarendon Street, New York State Energy Research and Development Authority, MA, Quality control, Growth, Community development, Renewable energy, Advent

View the full release here: https://www.businesswire.com/news/home/20230404005751/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230404005751/en/
    Massachusetts Governor Maura Healey with Advent Technologies Chairman and CEO Dr. Vasilis Gregoriou at the grand opening of the Company’s new facilities at Hood Park in Charlestown, (Boston), MA.
  • Guests toured Advent's new facility, which has:
    State-of-the-art coating machines that support the seamless transition from prototypes to initial production runs for advanced membranes and electrodes of fuel cells.
  • Fuel cell and electrolyzer test stations for statistical process control and development of next-generation membrane electrode assembly (“MEA”) materials.
  • Advent’s newly established facility is expected to create employment opportunities for fuel cell engineers and material scientists in Massachusetts and further contribute to the growth of the clean energy sector.

EQS-News: CEWE is planning another increase in turnover and earnings in 2023

Retrieved on: 
金曜日, 3月 31, 2023
Online, Nature, Sustainability reporting, Calendar, Annual, Annual general meeting, EBT, EBIT, SDAX, COP, XXL, Executive Board of the European Central Bank, Annual report, ROCE, TIPA, Supervisory board, Advent, ISIN, Commercial, Security (finance), Holding company, Cryptocurrency

The dividend for the financial year 2022 is to increase to 2.45 euros per share (previous year: 2.35 euros).

Key Points: 
  • The dividend for the financial year 2022 is to increase to 2.45 euros per share (previous year: 2.35 euros).
  • Subject to the approval of the Annual General Meeting, this is the fourteenth dividend increase in a row.
  • CEWE is thus one of the top 5 German index companies with a dividend that has been increasing for so many years.
  • Group turnover in 2023 is expected to be in the range of 720 to 780 million euros.

Advent Technologies' Chairman and CEO, Dr. Vasilis Gregoriou Elected as Chair of EU IPCEI Hy2Tech Group

Retrieved on: 
水曜日, 3月 29, 2023
Technology, Engineering, Automotive Manufacturing, Aerospace, Manufacturing, Alternative Vehicles, Fuels, Automotive, Batteries, Alternative Energy, Energy, Environment, Sustainability, Hardware, Green Technology, Hydrogen, Proton, Climate, European Union's scientific cooperation beyond the bloc, Assembly, Life, German, Economy, University, ADN, Research, Multimedia, Ministry of Economic Affairs and Climate Policy, REPowerEU, Federal Ministry of Science, Technology and Innovation, The Cults of the Greek States, AVL, Government, Green, Ministry, General assembly, Trust, Hellenic State (1941–1944), European, Advent, High Temperature Proton Exchange Membrane fuel cell, Knowledge, Policy, R, Hipo, SME, Renewable energy, EU

View the full release here: https://www.businesswire.com/news/home/20230329005582/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230329005582/en/
    Dr. Vasilis Gregoriou (Chairman and CEO, Advent Technologies) during the 1st General Assembly for Hy2Tech and Hy2Use in Berlin, Germany.
  • Richard Schauperl, Senior Project Manager, R&D Hydrogen and Fuel Cell at AVL GmbH, was also elected as the Deputy Chair of the Facilitation Group.
  • Advent’s Green HiPo is one of 41 projects ratified under IPCEI Hy2Tech, jointly prepared and notified by fifteen Member States.
  • Dr. Vasilis Gregoriou, Advent's Chairman and CEO, commented, "I am deeply honored to have been elected as the Chair of the Facilitation Group for IPCEI Hy2Tech, and I am grateful for the trust and support from my fellow industry leaders.

Advent International Appoints Biopharma Executive James Mullen as Operating Partner

Retrieved on: 
火曜日, 3月 28, 2023
Professional Services, Health, Finance, Asset Management, Pharmaceutical, Biotechnology, Patent, Bachelor of Science in Human Biology, Executive, Pronova BioPharma, International, Cas9, MBA, Research, DSM-IV codes, Villanova University, Thermo Fisher Scientific, Cas12a, Rensselaer Polytechnic Institute, Patient, Chemical engineering, Advent, Advent International, Knowledge, Biogen, Fine chemical, Pharmaceutical industry, Science, Patheon, Editas Medicine

Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of seasoned biopharma executive James (“Jim”) Mullen as an Operating Partner.

Key Points: 
  • Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of seasoned biopharma executive James (“Jim”) Mullen as an Operating Partner.
  • “Jim has been a renowned leader in the biopharma sector for over four decades,” said John Maldonado, Managing Partner at Advent.
  • Mullen currently serves as the Executive Chairman of Editas Medicine, a leading genome editing company, where he previously served as the company’s President and CEO.
  • Mullen served as the CEO and director of Patheon, a pharmaceutical and manufacturing organization serving the pharmaceutical and biotechnology sectors.